Goodwin F K, Ghaemi S N
The Center on Neuroscience, Medical Progress, and Society Department of Psychiatry, George Washington University, Washington DC, USA.
Dialogues Clin Neurosci. 1999 Jun;1(1):41-51. doi: 10.31887/DCNS.1999.1.1/fgoodwin.
Bipolar disorder's unique combination of three characteristics - clear genetic diathesis, distinctive clinical features, early availability of an effective treatment (lithium) - explains its special place in the history of psychiatry and its contribution to the current explosive growth of neuroscience. This article looks at the state of the art in bipolar disorder from the vantage point of: (i) genetics (possible linkages on chromosomes 18 and 21q, polygenic hypothesis, research into genetic markers); (ii) diagnosis (new focus on the subjective aspects of bipolar disorder to offset the current trend of underdiagnosis due to overreliance on standardized interviews and rating scales); (iii) outcome (increase in treatment-resistant forms signaling a change in the natural history of bipolar disorder); (iv) pathophysiology (research into circadian biological rhythms and the kindling hypothesis to explain recurrence); (v) treatment (emergence of the anticonvulsants, suggested role of chronic antidepressant treatment in the development of treatment resistance); (vi) neurobiology (evaluation of regulatory function in relation to affective disturbances, role of postsynaptic second-messenger mechanisms, advances in functional neuroimaging); and (vii) psychosocial research (shedding overly dualistic theories of the past to understand the mind and brain as an entity, thus emphasizing the importance of balancing the psychopharmacological and psychotherapeutic approaches). Future progress in the understanding and treatment of bipolar disorder will rely on successful integration of the biological and psychosocial lines of investigation.
双相情感障碍具有三个独特特征的组合——明确的遗传易感性、独特的临床特征、有效治疗方法(锂盐)的早期可得性——这解释了其在精神病学史上的特殊地位以及对当前神经科学爆发式发展的贡献。本文从以下几个角度审视双相情感障碍的当前研究现状:(i)遗传学(18号和21q染色体上可能的连锁关系、多基因假说、遗传标记研究);(ii)诊断(对双相情感障碍主观方面的新关注,以抵消当前因过度依赖标准化访谈和评定量表而导致的诊断不足趋势);(iii)转归(难治性形式的增加表明双相情感障碍自然病程的变化);(iv)病理生理学(对昼夜生物节律和点燃假说的研究以解释复发);(v)治疗(抗惊厥药物的出现、慢性抗抑郁治疗在治疗抵抗发生中的潜在作用);(vi)神经生物学(评估与情感障碍相关的调节功能、突触后第二信使机制的作用、功能神经影像学的进展);以及(vii)社会心理研究(摒弃过去过于二元化的理论,将心智和大脑视为一个整体,从而强调平衡心理药物治疗和心理治疗方法的重要性)。双相情感障碍在理解和治疗方面的未来进展将依赖于生物和社会心理研究路线的成功整合。